A DNA G-Quadruplex-Targeting Ligand Suppresses c-MYC Expression: Implications for Gemcitabine‑Resistant Pancreatic Cancer.
The MYC oncogene is dysregulated in nearly 70% of human cancers and plays a central role in tumor initiation and progression. However, direct targeting of c-MYC remains challenging because of its "undruggable" nature. Stabilization of DNA G-quadruplex (G4) structures within the c-MYC promoter offers an alternative stra...